October 19, 2018 · STOCK Act disclosure
Senator Mark R. Warner (Democrat-VA) bought Acumen Pharmaceuticals, Inc. Company: Acumen Pharmaceuticals, Inc. (San Francisco, CA) Description: Drug Discovery, a stock transaction, valued at $100,001 - $250,000. The trade took place on October 19, 2018 and was disclosed on November 8, 2018 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.
Acumen Pharmaceutical, Inc. Company: Acumen Pharmaceutical, Inc. (Livermore, CA) Description: Drug Discovery